[Current aspects of clinical bronchopulmonary and cardiovascular clinical pharmacology. Talampicillin in acute bronchopulmonary diseases in mine workers].
The results observed with talampicilline in our clinical study confirmed the observations made by others regarding the activity and the improved tolerance for this drug versus ampicilline. The use of a high daily dosage of 3 g per day was neither a cause of more frequent nor more severe side-effects than the usually smaller posology used in other studies published in the literature.
D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000031:analogs & derivatives*; D005069:Evaluation Studies as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D008906:Mining; D011009:Pneumoconiosis / Q000150:complications; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy*; D013626:Talampicillin / Q000008:administration & dosage* / Q000009:adverse effects
D013626:Talampicillin; D000667:Ampicillin
Aktualiteiten van bronchopulmonaire en cardiovasculaire klinische farmacologie. Talampicilline in acute borncho-pulmonaire aandoeningen bij mijnwerkers.